Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update
The vascular endothelium is a dynamic, functionally complex organ, modulating multiple
biological processes, including vascular tone and permeability, inflammatory responses …
biological processes, including vascular tone and permeability, inflammatory responses …
[HTML][HTML] Update on fibroblast growth factor 23 in chronic kidney disease
M Wolf - Kidney international, 2012 - Elsevier
Chronic kidney disease (CKD) is a public health epidemic that affects millions of people
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …
Effects of phosphate binders in moderate CKD
GA Block, DC Wheeler, MS Persky… - Journal of the …, 2012 - journals.lww.com
Some propose using phosphate binders in the CKD population given the association
between higher levels of phosphorus and mortality, but their safety and efficacy in this …
between higher levels of phosphorus and mortality, but their safety and efficacy in this …
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD)
M Ruospo, SC Palmer, P Natale… - Cochrane Database …, 2018 - cochranelibrary.com
Background Phosphate binders are used to reduce positive phosphate balance and to lower
serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …
serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
JJ Scialla, M Wolf - Nature Reviews Nephrology, 2014 - nature.com
Disturbances in phosphate homeostasis are common in patients with chronic kidney
disease. As kidney function declines, circulating concentrations of phosphate and the …
disease. As kidney function declines, circulating concentrations of phosphate and the …
Biological variability of plasma intact and C-terminal FGF23 measurements
ER Smith, MM Cai, LP McMahon… - The Journal of Clinical …, 2012 - academic.oup.com
Context: FGF23 measurement may have a role in the management of patients with chronic
kidney disease (CKD). Objective: Our objective was to study the biological variability of …
kidney disease (CKD). Objective: Our objective was to study the biological variability of …
[HTML][HTML] Phosphate—a poison for humans?
H Komaba, M Fukagawa - Kidney international, 2016 - Elsevier
Maintenance of phosphate balance is essential for life, and mammals have developed a
sophisticated system to regulate phosphate homeostasis over the course of evolution …
sophisticated system to regulate phosphate homeostasis over the course of evolution …
Cellular clearance and biological activity of calciprotein particles depend on their maturation state and crystallinity
S Köppert, A Büscher, A Babler, A Ghallab… - Frontiers in …, 2018 - frontiersin.org
Background: The liver-derived plasma protein fetuin-A is a systemic inhibitor of ectopic
calcification. Fetuin-A stabilizes saturated mineral solutions by forming colloidal protein …
calcification. Fetuin-A stabilizes saturated mineral solutions by forming colloidal protein …
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
MG Vervloet, ZA Massy, VM Brandenburg… - The lancet Diabetes & …, 2014 - thelancet.com
Recent reports of several bone-derived substances, some of which have hormonal
properties, have shed new light on the bone–cardiovascular axis. Deranged concentrations …
properties, have shed new light on the bone–cardiovascular axis. Deranged concentrations …
Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD
Patients with CKD often progress to ESRD and develop cardiovascular disease (CVD), yet
available therapies only modestly improve clinical outcomes. Observational studies report …
available therapies only modestly improve clinical outcomes. Observational studies report …